1. Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives

   • Shelly Heath-Watson
   • Sangeeta Sule

   Commentary Open access 26 February 2018 Pages: 1 - 4

2. Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases

   • Gergely Bodis
   • Victoria Toth
   • Andreas Schwarting

   Review Open access 07 March 2018 Pages: 5 - 20

3. A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases

   • Andrea Rubbert-Roth
   • Daniel E. Furst
   • Erhan Berber

   Review Open access 03 March 2018 Pages: 21 - 42

   

4. Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis

   • Alvin F. Wells
   • Maria Greenwald
   • Cynthia E. Kartman

   Original Research Open access 21 April 2018 Pages: 43 - 55

   

5. Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

   • Rebekah H. Borse
   • Sumesh Kachroo
   • Ralph P. Insinga

   Original Research Open access 09 April 2018 Pages: 57 - 73

   

6. Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study

   • Louis Bessette
   • Gerald Lebovic
   • Carter Thorne

   Original Research Open access 09 April 2018 Pages: 75 - 85

   

7. Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach

   • Finbar O’Shea
   • Peter C. Taylor
   • Sumesh Kachroo

   Original Research Open access 03 April 2018 Pages: 87 - 98

   

8. Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

   • Peter Nash
   • Iain B. McInnes
   • Steffen M. Jugl

   Original Research Open access 31 March 2018 Pages: 99 - 122

   

9. Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial

   • Gurjit S. Kaeley
   • Daryl K. MacCarter
   • Jasmina Kalabic

   Original Research Open access 24 March 2018 Pages: 123 - 134

   

10. Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan

    • Masateru Okazaki
    • Hisanori Kobayashi
    • Masayoshi Kanbori

    Original Research Open access 02 March 2018 Pages: 135 - 148

    

11. Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis

    • Hassan Bassiouni
    • Catherine Elizabeth Spargo
    • Khalid Shirazy

    Original Research Open access 26 February 2018 Pages: 149 - 158

    

12. Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States

    • Amanda M. Kong
    • Gilwan Kim
    • Jennie H. Best

    Original Research Open access 22 February 2018 Pages: 159 - 170

    

13. Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data

    • Florent Guelfucci
    • Yuko Kaneko
    • Rosarin Sruamsiri

    Original Research Open access 22 February 2018 Pages: 171 - 183

    

14. Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients

    • Masateru Okazaki
    • Hisanori Kobayashi
    • Tsutomu Yajima

    Original Research Open access 22 February 2018 Pages: 185 - 201

    

15. Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis

    • Roy Fleischmann
    • Jürgen Wollenhaupt
    • Michael E. Weinblatt

    Original Research Open access 07 February 2018 Pages: 203 - 214

    

16. Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study

    • Cynthia J. Larmore
    • Natalie N. Boytsov
    • Leslie R. Harrold

    Original Research Open access 10 January 2018 Pages: 215 - 229

    

17. Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis

    • Alan Kivitz
    • Lydie Baret-Cormel
    • Marina Stanislav

    Original Research Open access 05 December 2017 Pages: 231 - 242

    

18. Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice

    • Fernando Perez Ruiz
    • Carlos A. Sanchez-Piedra
    • Francisca Sivera

    Original Research Open access 04 December 2017 Pages: 243 - 253

19. A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States

    • Christina A. Spivey
    • Jenny Griffith
    • Junling Wang

    Original Research Open access 04 December 2017 Pages: 255 - 270

    

20. A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia

    • Chad S. Boomershine
    • Todd A. Koch
    • David Morris

    Original Research Open access 17 November 2017 Pages: 271 - 281

    

21. Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis

    • Stanley Cohen
    • Jeffrey R. Curtis
    • Roy Fleischmann

    Brief Report Open access 22 February 2018 Pages: 283 - 291

    

22. A Case Report of Chikungunya Fever, Rheumatoid Arthritis, and Felty’s Syndrome

    • José Kennedy Amaral
    • Robert T. Schoen

    Case Report Open access 13 March 2018 Pages: 293 - 301

    

23. A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout

    • Daniela Marotto
    • Antonella De Santis
    • Stefano Del Giacco

    Case Report Open access 09 March 2018 Pages: 303 - 310